Divi's Laboratories shares hit record high rising 84% YTD; buy, sell or hold after Q2 results 2026? Brokerages report
Divi’s Laboratories shares surged to a fresh 52-week high after strong Q2 FY27 results and positive broker commentary. Net profit rose 64% year-on-year to ₹1,127 crore, while revenue grew 35% to ₹3,676 crore. Brokerages highlighted growth potential in custom synthesis and peptides.
Read the full story at Livemint →